Vir Biotechnology, Inc.

VIR

Exchange: Nasdaq
Industry: Biological Products, (No Diagnostic Substances)
SEC CIK: 0001706431

SEC filings (opens in a new tab)

No open-market purchases or sales by Vir Biotechnology, Inc. insiders were filed in the last 90 days; 237 institutions reported holding it in 13F filings for Q2 2026, worth $1.49B in total; no superinvestor holds it.

Q4 2024 vs. Q3 2024

How the institutions holding Vir Biotechnology, Inc. changed between Q3 2024 and Q4 2024.

All holders in Q4 2024 All holders in Q3 2024

13F holders of VIR: Q3 2024 compared with Q4 2024
Measure	Q3 2024	Of which not filed for Q4 2024	Q4 2024	Change
Holders	197	2	208	+13
Shares	87.6M	1.56M	88.8M	+2.74M (+3.2%)
Value	$656.3M	$11.7M	$652.0M	+$7.45M (+1.2%)

2 institutions that held it in Q3 2024 haven't filed for Q4 2024 yet. Not filing isn't selling, so the changes leave them out.

New holders (42)

Institutions that held Vir Biotechnology, Inc. at the end of Q4 2024 but not at the end of Q3 2024.

Institutions new to VIR in Q4 2024
Institution	Shares	Value	% of portfolio
Baker Bros. Advisors LP	1,084,539	$7.96M	0.09%
Sio Capital Management, LLC	1,054,651	$7.74M	2.18%
Artisan Partners Limited Partnership	918,529	$6.74M	0.01%
Ikarian Capital, LLC	897,862	$6.59M	1.88%
Alta Partners Management Company, L.P.	489,485	$3.59M	5.67%
Standard Life Aberdeen plc	363,161	$2.67M	0.01%
Boothbay Fund Management, LLC	260,371	$1.91M	0.06%
ExodusPoint Capital Management, LP	246,833	$1.81M	0.02%
Susquehanna Fundamental Investments, LLC	201,185	$1.48M	0.02%
Group One Trading, L.P.	179,262	$1.32M	0.04%
Stonepine Capital Management, LLC	164,106	$1.20M	0.97%
Woodline Partners LP	135,036	$991.2K	0.01%
Alps Advisors Inc	111,360	$817.4K	0.01%
DAFNA Capital Management LLC	100,000	$734.0K	0.19%
Quinn Opportunity Partners LLC	65,976	$484.3K	0.03%
Tejara Capital Ltd	51,967	$381.4K	0.25%
Fox Run Management, L.L.C.	49,651	$364.4K	0.07%
Persistent Asset Partners Ltd	24,069	$250.3K	0.21%
Lightspeed Management Company, L.L.C.	28,421	$208.6K	0.07%
HSBC Holdings PLC	26,309	$192.4K	0.00%
XTX Topco Ltd	24,085	$176.8K	0.01%
Marshall Wace, LLP	23,557	$172.9K	0.00%
Wolverine Trading, LLC	23,406	$171.6K	0.00%
Brevan Howard Capital Management LP	20,633	$151.4K	0.00%
Police & Firemen's Retirement System of New Jersey	18,316	$134.4K	0.00%
SEI Investments Co	17,240	$126.5K	0.00%
KLP Kapitalforvaltning AS	16,200	$118.9K	0.00%
Creative Planning	14,188	$104.1K	0.00%
Polymer Capital Management (US) LLC	13,790	$101.2K	0.03%
Virtu Financial LLC	12,836	$94.0K	0.00%
First Trust Advisors LP	12,656	$92.9K	0.00%
BNP Paribas Arbitrage, SA	12,490	$91.7K	0.00%
Nebula Research & Development LLC	11,445	$84.0K	0.01%
Syon Capital LLC	10,534	$77.3K	0.01%
CIBC Asset Management Inc	10,132	$74.4K	0.00%
SBI Securities Co., Ltd.	8,222	$60.3K	0.00%
Point72 Asia (Singapore) Pte. Ltd.	5,690	$41.8K	0.01%
GF Fund Management Co. Ltd.	2,892	$21.2K	0.00%
BFSG, LLC	1,000	$7.34K	0.00%
Capital A Wealth Management, LLC	41	$301	0.00%
Principal Securities, Inc.	16	$117	0.00%
Skopos Labs, Inc.	1	$8	0.00%

Sold out (29)

Institutions that held Vir Biotechnology, Inc. at the end of Q3 2024 and filed for Q4 2024 without it.

Institutions that sold out of VIR in Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Baillie Gifford & Co	2,383,029	$17.8M
Jefferies Financial Group Inc.	1,085,210	$8.13M
Jacobs Levy Equity Management, Inc	350,265	$2.62M
PDT Partners, LLC	220,821	$1.65M
Trexquant Investment LP	196,991	$1.48M
Corton Capital Inc.	102,400	$767.0K
Franklin Resources Inc	97,948	$751.3K
Tudor Investment Corp Et Al	68,113	$510.2K
Schonfeld Strategic Advisors LLC	52,276	$391.5K
Magnetar Financial LLC	41,891	$313.8K
Hennion & Walsh Asset Management, Inc.	35,132	$263.1K
Valence8 US LP	33,650	$252.0K
Jump Financial, LLC	32,862	$246.1K
Handelsbanken Fonder AB	26,400	$198.0K
Y-Intercept (Hong Kong) Ltd	22,455	$168.2K
Sherbrooke Park Advisers LLC	19,719	$147.7K
Cerity Partners LLC	16,435	$123.1K
Everence Capital Management Inc	12,780	$96.0K
NorthCrest Asset Manangement, LLC	11,700	$87.6K
E Fund Management Co., Ltd.	11,170	$83.7K
Cornercap Investment Counsel Inc	10,587	$79.3K
nVerses Capital, LLC	7,500	$56.2K
Ronald Blue Trust, Inc.	3,989	$35.5K
Farther Finance Advisors, LLC	485	$3.63K
Versant Capital Management, Inc	391	$2.93K
Bessemer Group Inc	140	$1.00K
Private Wealth Management Group, LLC	51	$382
AdvisorNet Financial, Inc	30	$225
Mendota Financial Group, LLC	6	$45

Not filed for Q4 2024 yet (2)

Institutions that held Vir Biotechnology, Inc. at the end of Q3 2024 and haven't filed a 13F for Q4 2024. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding VIR in Q3 2024 that haven't filed for Q4 2024
Institution	Shares, Q3 2024	Value, Q3 2024
Bill & Melinda Gates Foundation	1,559,142	$11.7M
FinTrust Capital Advisors, LLC	14	$105